AUTHOR CONTRIBUTIONS
XS, BC, and SZ designed the study. XS, CH, NH, BC, and SZ performed the
experiments. XS, BC, and SZ analyzed the data, and XS wrote the paper
with help from all authors.
REFERENCES
1. Cao Z, Gao W, Bao H, Feng H, Mei S,
Chen P, Gao Y, Cui Z, Zhang Q, Meng X et al : VV116 versus
Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19 . N Engl J
Med 2022.
2. COVID-19 Excess Mortality
Collaborators. Estimating excess mortality due to the COVID-19 pandemic:
a systematic analysis of COVID-19-related mortality, 2020-21 (vol 399,
pg 1513, 2022) . Lancet 2022, 399 (10334):1468-1468.
3. Abdool Karim SS, de Oliveira T:New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine
Implications . N Engl J Med 2021, 384 (19):1866-1868.
4. Machhi J, Herskovitz J, Senan AM,
Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel Met al : The Natural History, Pathobiology, and Clinical
Manifestations of SARS-CoV-2 Infections . Journal of neuroimmune
pharmacology : the official journal of the Society on NeuroImmune
Pharmacology 2020, 15 (3):359-386.
5. Li DD, Zhang JW, Li JM:Primer design for quantitative real-time PCR for the emerging
Coronavirus SARS-CoV-2 . Theranostics 2020,10 (16):7150-7162.
6. Menni C, Valdes AM, Polidori L,
Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu Cet al : Symptom prevalence, duration, and risk of hospital
admission in individuals infected with SARS-CoV-2 during periods of
omicron and delta variant dominance: a prospective observational study
from the ZOE COVID Study . Lancet 2022,399 (10335):1618-1624.
7. Markewitz RDH, Wandinger KP, Junker
R: Saliva for Detection of SARS-CoV-2 . N Engl J Med2021, 384 (9):e31.
8. Wyllie AL, Fournier J,
Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL,
Geng B, Muenker MC, Moore AJ et al : Saliva or
Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 . N Engl
J Med 2020, 383 (13):1283-1286.
9. Drain PK: Rapid Diagnostic
Testing for SARS-CoV-2 . N Engl J Med 2022,386 (3):264-272.